Back to top

Imax price target raised to $50 from $47 at Rosenblatt

Rosenblatt raised the firm’s price target on Imax (IMAX) to $50 from $47 and keeps a Buy rating on the shares. The company delivered better-than-ex...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ImageneBio, Inc. (IMA)

IMAX Corporation (IMAX)